JEA BizDev Consulting, LLC®
Let’s connect
JEA BizDev Consulting, LLC®

Science. Strategy. Partnership.

Reference libraries
My cross-border dealsCross-border deal library
Start a conversation
North America · Europe · Asia

Find your next opportunity.

HomeConnecting science. Creating value.PagesServicesExpertise across the BD value chainPagesAbout JohnExperience behind the partnershipsPagesOur approachFrom strategy to signed agreementPagesOpportunitiesExplore assets for partneringPagesTrack recordPartnerships and downloadable deal summariesPagesStart a conversationDiscuss an opportunity with JohnPagesMy cross-border dealsJEA reference library on Google DriveTransactionsCross-border deal libraryJEA reference library on Google DriveTransactionsDLL3 ADCOncology · IND Filing · DLL3AssetsHER2 Biparatopic ADCOncology · Phase 3 · HER2AssetsFRα Biparatopic ADCOncology · IND Filing · FRαAssetsCYP11B2 InhibitorCardiovascular · IND Filing · CYP11B2AssetsENPP1 InhibitorCardiovascular · IND Approved · ENPP1AssetsB7-H3 ADCOncology · Phase 1 · B7-H3AssetsATM InhibitorOncology · Phase 1 · ATMAssetsKAT6 InhibitorOncology · Phase 1 · KAT6A / KAT6BAssetsEGFR-ADCOncology · Phase 3 · EGFRAssetsNovaRock × Bionyra (2026)Exclusive license agreement for NBL-023, a novel anti–IL-25 monoclonal antibody, granting worldwide rights outside Greater China.TransactionsNovaRock × LigaChemBio (2026)Global out-licensing agreement for an ADC candidate targeting a novel oncology antigen.TransactionsCSPC × Radiance Biopharma (2025)$1,240 million strategic partnership for ROR1-ADC (SYS6005).TransactionsCSPC × Cipla (2025)$1,065 million strategic partnership for an Irinotecan Liposomal Injection product.TransactionsNovaRock × LigaChemBio (2025)Two global out-licensing agreements for novel antibodies.Transactions
↑ ↓ Navigate · Enter Open · Esc Close

YOUR INFORMATION

Privacy, with clarity.

Access JEA’s privacy policy and understand how the website’s inquiry form handles your information.

JEA’s privacy policy

The existing JEA BizDev Consulting privacy policy is available in its original format.

Read the privacy policy (PDF)

When you get in touch

The inquiry form asks for your contact details, company, and a non-confidential description of your priorities. Entering your information keeps those details in the current browser tab. Choosing “Send inquiry” submits them through the website’s Formcarry delivery service so JEA can respond.

Website analytics

The production website retains Vercel Web Analytics for aggregate website usage. Inquiry text is not added to analytics events.

Questions

For questions about your information, contact jeabizdev@gmail.com.